By expenditures
| Name | Title | Type |
|---|---|---|
| Joe Harnisch | Chief Financial Officer | Auditee |
| Rebekah Martin | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 372942 | 2025 | 2025-12-03 | BAKER TILLY US LLP | $13.14M |
| 344747 | 2024 | 2025-03-04 | Baker Tilly US LLP | $13.62M |
| 292453 | 2023 | 2024-02-27 | Baker Tilly US LLP | $13.02M |
| 54189 | 2022 | 2023-02-26 | Baker Tilly US LLP | $15.39M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 372942 | 2025 | 2025-12-03 | 1163423 | 2025-002 | Material Weakness | Yes | N |
| 372942 | 2025 | 2025-12-03 | 1163422 | 2025-001 | Material Weakness | Yes | N |
| 344747 | 2024 | 2025-03-04 | 1102072 | 2024-001 | - | - | N |
| 344747 | 2024 | 2025-03-04 | 525630 | 2024-001 | - | - | N |
| 292453 | 2023 | 2024-02-27 | 947232 | 2023-002 | Significant Deficiency | Yes | N |
| 292453 | 2023 | 2024-02-27 | 947231 | 2023-001 | Significant Deficiency | Yes | N |
| 292453 | 2023 | 2024-02-27 | 370790 | 2023-002 | Significant Deficiency | Yes | N |
| 292453 | 2023 | 2024-02-27 | 370789 | 2023-001 | Significant Deficiency | Yes | N |
| 54189 | 2022 | 2023-02-26 | 634823 | 2022-003 | Significant Deficiency | Yes | L |
| 54189 | 2022 | 2023-02-26 | 634822 | 2022-003 | Significant Deficiency | Yes | L |
| 54189 | 2022 | 2023-02-26 | 634821 | 2022-001 | Significant Deficiency | - | N |
| 54189 | 2022 | 2023-02-26 | 634820 | 2022-002 | Significant Deficiency | - | N |
| 54189 | 2022 | 2023-02-26 | 634819 | 2022-001 | Significant Deficiency | - | N |
| 54189 | 2022 | 2023-02-26 | 58381 | 2022-003 | Significant Deficiency | Yes | L |
| 54189 | 2022 | 2023-02-26 | 58380 | 2022-003 | Significant Deficiency | Yes | L |
| 54189 | 2022 | 2023-02-26 | 58379 | 2022-001 | Significant Deficiency | - | N |
| 54189 | 2022 | 2023-02-26 | 58378 | 2022-002 | Significant Deficiency | - | N |
| 54189 | 2022 | 2023-02-26 | 58377 | 2022-001 | Significant Deficiency | - | N |